AIM To study the pharmacokinetics and bioequivalence of domestic and imported micronised fenofibrate capsual in healthy volunteers.METHODS The study was designed in 20 healthy volunteers according a two-treatment , two-period , two-sequence randomized cross-over trial.Plasma concentrations were determined by HPLC method, ketoprofen was used as the internal standard.The pharmacokinetics parameters were calculated statistically to evaluate the bioequivalence between the tow preparations by BAPP2.2 software.